Completed OBSERVATIONAL NCT03737435

Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study (Micros)

Sponsor: Istituto Ortopedico Rizzoli

Updated 12 times since 2018 Last updated: Sep 19, 2025 Started: Dec 12, 2018 Primary completion: Oct 25, 2024 Completion: Oct 25, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03737435, this observational or N/A phase trial focuses on Localized Osteosarcoma and remains completed. Sponsored by Istituto Ortopedico Rizzoli, it has been updated 12 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

12 versions recorded

Oct 2025 — Present [monthly]

Completed

Status: Recruiting → Completed
Sep 2024 — Oct 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting
Jun 2023 — Apr 2024 [monthly]

Recruiting

▶ Show 7 earlier versions

Dec 2021 — Jun 2023 [monthly]

Recruiting
Sep 2021 — Dec 2021 [monthly]

Recruiting

Status: Unknown Status → Recruiting
Jan 2021 — Sep 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Mar 2019 — Nov 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jan 2019 — Mar 2019 [monthly]

Not Yet Recruiting
Dec 2018 — Jan 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istituto Ortopedico Rizzoli

Data source: Istituto Ortopedico Rizzoli

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bologna, Italy